Results 261 to 270 of about 138,294 (305)
Some of the next articles are maybe not open access.

Gastrointestinal mucormycosis in immunocompromised hosts

Mycoses, 2015
SummaryInvasive mucormycosis is a rare fungal infection in immunocompromised hosts, but it carries a high mortality rate. Primary gastrointestinal disease is the least frequent form of presentation. Early diagnosis and treatment are critical in the management; however, symptoms are typically non‐specific in gastrointestinal disease, leading to delayed ...
M Veronica, Dioverti   +5 more
openaire   +2 more sources

Travel and the immunocompromised host

Hospital Medicine, 2000
Increasing opportunities for travel and advances in medicine mean that immunocompromised patients may venture to potentially risky parts of the world. This article examines the risks faced by such travellers. Some limitations of standard travel vaccines are discussed and suggestions are made as to how best to advise such travellers.
openaire   +2 more sources

Infection in the immunocompromised host

The Pediatric Infectious Disease Journal, 1985
The largest numbers of immunocompromised pediatric patients are neonates and children who are managed in intensive care units. Therapeutic principles that apply to the classic neutropenic cancer patient are also relevant for these categories; maximum doses of bactericidal antibiotics given for longer periods should be used. Pediatricians should also be
openaire   +3 more sources

The Immunocompromised Host

1990
An immunocompromised host is an individual whose immune defense mechanisms are impaired. This may be due to decreased antibody formation (B lymphocyte function), cell-mediated immunity (T lymphocyte function), granulocyte function, or a combination of these.
openaire   +1 more source

Mucormycosis in the immunocompromised host

Infection, 1983
We are presenting two typical case histories of mucormycosis in patients with acute leukaemia which illustrate some of the important features of this infection in compromised hosts. In such patients, mucormycosis is mostly pulmonary or widely disseminated and often has a rapidly fatal course.
S, Bhaduri   +3 more
openaire   +2 more sources

Sinusitis in the immunocompromised host

Current Infectious Disease Reports, 1999
Sinusitis occurs in a wide range of immunocompromised hosts, including neutropenic patients, diabetic patients, patients in critical care units, and patients with HIV infection. Reversal of underlying risk factors, such as neutropenia or diabetic ketoacidosis, is essential in the treatment of fungal rhinosinusitis.
openaire   +2 more sources

Gastrointestinal infections in immunocompromised hosts

Current Opinion in Internal Medicine, 2006
Gastrointestinal infections in the immunocompromised host continue to have significant morbidity and mortality throughout the world. They all have similar exposures to viruses, bacteria and parasites and respond to these infections in a similar way. This review will summarize the latest reports on the epidemiology, diagnosis and treatment of known and ...
Kerri, Thom, Graeme, Forrest
openaire   +2 more sources

The Immunocompromised Host

2010
1 Genetic Disorders of Innate Immunity 2 Genetic Disorders at the Interface between Innate and Adaptive Immunity 3 Genetic Disorders of Adaptive Immunity Keywords: immunocompromised host; genetic disorders of innate immunity; genetic disorders at interface between innate and adaptive immunity; inherited severe congenital ...
openaire   +1 more source

Antifungal Prophylaxis in Immunocompromised Hosts

Annals of Pharmacotherapy, 1993
OBJECTIVE: To review the literature on the efficacy and safety of antifungal agents for prophylaxis of fungal infections in populations of immunocompromised hosts (key words: hematology-oncology, surgical, solid organ transplant, HIV infection), and to develop guidelines and recommendations regarding safe and effective drug regimens for antifungal ...
S, Reents, S D, Goodwin, V, Singh
openaire   +2 more sources

Management of the Immunocompromised Host

Medical Clinics of North America, 1984
This article deals with the management of the immunocompromised host. Mechanisms of immunocompromise include alterations in skin and mucosal barriers, normal oral and intestinal flora, splenic function, and number or function of T cells, B cells, granulocytes, and monocytes.
openaire   +2 more sources

Home - About - Disclaimer - Privacy